Skip to main content
. 2019 Jun 27;123(2):135–150. doi: 10.1016/j.bja.2019.04.062

Table 2.

Selected retrospective studies of regional anaesthesia and clinical outcomes. BCR, biochemical recurrence; CSS, cancer-specific survival; GA, general anaesthesia; HR, hazard ratio; OR, odds ratio; OS, overall survival; PCA, patient-controlled analgesia; PFS, progression-free survival; PVB, paravertebral block; RCT-PHA, RCT-post hoc analysis; RFS, recurrence-free survival; TURBT, trans-urethral resection of bladder tumour; PCEA, patient-controlled epidural analgesia.

Study authors Year Type Surgery type Techniques compared Significant results
Biki and colleagues76 2008 RC Radical prostatectomy GA+epidural (n=102); GA+opioid (n=123) 57% reduction in BCR in epidural group
Tsui and colleagues78 2010 RCT-PHA Radical prostatectomy GA+epidural (n=49); GA (n=50) No difference in disease-free survival
Wuethrich and colleagues79 2010 RC Radical prostatectomy GA+epidural (n=105); GA+opioid/NSAID (n=158) Improved PFS in epidural group (HR: 0.45); no difference in BCR, CSS, or OS
Forget and colleagues80 2011 RC Radical prostatectomy GA+epidural (n=578); GA (n=533) No difference in BCR-free survival
Wuethrich and colleagues81 2013 RC Radical prostatectomy GA+epidural (n=67); GA+opioid/NSAID (n=81) No difference in BCR, RFS, or OS
Roiss and colleagues82 2014 RC Radical prostatectomy GA+spinal (n=3047); GA alone (n=1725) No difference in BCR, RFS, or OS
Sprung and colleagues83 2014 RC Radical prostatectomy GA+epidural (n=486); GA+opioids (n=486) No difference in RFS, CSS, or OS
Scavonetto and colleagues84 2014 RC Radical prostatectomy GA+neuraxial (n=1642); GA alone (n=1642) GA alone associated with increased systemic progression (HR: 2.81; P=0.008) and mortality (HR: 1.32; P=0.047)
Tseng and colleagues85 2014 RC Radical prostatectomy Spinal+sedation (n=1166); GA (n=798) No difference in BCR
Lee and colleagues86 2017 RC Thoracotomy for lung cancer GA+epidural (n=619); GA+PVB (n=536); GA+PCA (n=574) PVB associated with increased OS; no difference with epidural or PCA; no difference in recurrence between the three groups
Christopherson and colleagues87 2008 RCT-PHA Colectomy GA+epidural (n=85); GA (n=92) Improved OS with epidural in those without metastases at time of surgery, but only up to 1.46 yr postoperative
Gottschalk and colleagues88 2010 RC Colectomy GA+epidural (n=256); GA (n=253) No difference in RFS overall; improved RFS in patients aged >64 yr
Gupta and colleagues89 2011 RC Colectomy GA+epidural (n=562); GA+PCA (n=93) Epidural use for rectal (HR: 0.45) cancers associated with improved OS; no difference seen for colon cancers
Cummings and colleagues90 2012 RC Colectomy GA+epidural (n=9670); GA (n=32 481) Improved OS in epidural group (HR: 0.91), but no difference in cancer recurrence
Day and colleagues91 2012 RC Laparoscopic colectomy GA+epidural (n=107); GA+spinal (n=144); GA+PCA (n=173) No difference in OS or 5 yr disease-free survival
Holler and colleagues92 2013 RC Colectomy GA+epidural (n=442); GA (n=307) Improved OS in epidural group (HR: 0.73)
Vogelaar and colleagues93 2015 RC Colectomy GA+epidural (n=399); GA (n=189) Improved OS in GA group (HR: 0.77)
Hiller and colleagues94 2014 RC Gastrectomy or oesophagectomy GA+epidural (n=97); GA (n=43) Epidurals associated with improved OS and RFS at 2 yr in oesophagectomy group; no difference in gastrectomy group
Cummings and colleagues95 2014 RC Gastrectomy GA+epidural (n=766); GA (n=1979) No difference in OS or recurrence rate
Heinrich and colleagues96 2015 RC Oesophagectomy GA+epidural (n=118); GA (n=35) No difference in RFS or OS
Li and colleagues97 2016 RC Oesophagectomy GA+epidural (n=178); GA (n=178) No difference in OS or recurrence risk
Shin and colleagues98 2017 RC Gastrectomy Epidural PCA (n=4325); i.v. PCA (n=374) No difference in OS or RFS
Wang and colleagues99 2017 RC Gastrectomy GA+epidural (n=1390); GA (n=2856) Improved OS in epidural group (HR: 0.65)
Lacassie and colleagues100 2013 RC Advanced ovarian cancer GA+epidural (n=37); GA (n=43) No difference in OS or time to recurrence
Lin and colleagues101 2011 RC Ovarian serous adenocarcinoma GA+epidural (n=106); GA+opioids (n=37) Decreased OS in GA+opioids group (HR: 1.214)
de Oliveira and colleagues102 2011 RC Ovarian cancer debulking GA+epidural (n=55); GA (n=127) Intraoperative epidural use associated with reduced recurrence risk (HR: 0.37)
Capmas and colleagues103 2012 RC Ovarian cancer complete cytoreduction GA+PCEA (n=47); GA (n=47) No difference in OS or RFS
Tseng and colleagues104 2018 RC Ovarian cancer debulking GA+epidural (n=435); GA (n=213) Improved PFS and OS in epidural group
Doiron and colleagues105 2016 RC Radical cystectomy GA+epidural (n=887); GA (n=741) No difference in OS or CSS
Weingarten and colleagues106 2016 RC Radical cystectomy GA+spinal (n=195); GA (n=195) No difference in OS or RFS
Chipollini and colleagues107 2018 RC Radical cystectomy GA+epidural (n=215); GA (n=215) Worse RFS (HR: 1.67) and CSS (HR: 1.53) in epidural group
Choi and colleagues108 2017 RC TURBT Spinal (n=718); GA (n=158) Lower recurrence rate in spinal group (HR: 0.636)
Koumpan and colleagues109 2018 RC TURBT Spinal (n=135); GA (n=96) Increased recurrence rate (OR: 2.06) and earlier time to recurrence (HR: 1.57) in GA group
Zimmitti and colleagues110 2016 RC Colorectal liver metastectomy GA+epidural (n=390); GA (n=120) Epidural associated with improved RFS (HR: 0.74), but not OS
Exadaktylos and colleagues77 2006 RC Breast GA+PVB (n=50); GA+opioid (n=79) Increased recurrence-free survival in PVB group at 3 yr (88% vs 77%; P=0.012)
Myles and colleagues111 2011 RCT-PHA Abdominal cancer surgery GA+epidural (n=230); GA (n=216) No difference in OS or RFS